Literature DB >> 10865994

Signal transduction mediated by adhesion of human trabecular meshwork cells to extracellular matrix.

L Zhou1, E L Cheng, P Rege, B Y Yue.   

Abstract

In this study we investigated the signaling event induced by adhesion of human trabecular meshwork (TM) cells to extracellular matrix (ECM) elements such as fibronectin. The role of tyrosine phosphorylation in adhesion was evaluated. A number of intracellular entities involved in the adhesion-mediated pathways were identified. For the experiments, human TM cells were seeded onto fibronectin- or polylysine (negative control)-coated plates. Fifteen, 30, 90 and 240 min after the seeding, cell lysates were collected. Immunoblotting analysis revealed that tyrosine phosphorylation occurred within 15 min of adhesion of TM cells to fibronectin and the level increased with time. The phosphotyrosyl proteins had molecular masses 25-220 kDa. A much lower level of tyrosine phosphorylation was observed when cells were plated on polylysine. Immunoprecipitation experiments indicated that the phosphotyrosine-containing proteins included focal adhesion kinase, paxillin, phosphatidylinositol 3-kinase and mitogen activated protein kinase. Within 30 min of adherence to fibronectin, human TM cells immunostained for paxillin and phosphotyrosine and exhibited prominent focal contacts. When treated with tyrosine kinase inhibitors genistein and herbimycin A and a protein kinase C (PKC) pseudosubstrate peptide inhibitor, cell adhesion to fibronectin was compromised and focal contact formation was limited. These results demonstrated that in human TM cells, tyrosine kinase was activated upon their adherence to fibronectin. PKC also appeared to play a role in modulation of the cell-matrix adhesion process. The current study provides insight into the signaling pathways that are linked to the ECM-induced events in TM cells. Elucidation of the hierarchy of signal responses may help develop strategies manipulating the cell-matrix interactions in the TM system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865994     DOI: 10.1006/exer.1999.0806

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  7 in total

Review 1.  Extracellular matrix in the trabecular meshwork.

Authors:  Ted S Acott; Mary J Kelley
Journal:  Exp Eye Res       Date:  2008-01-25       Impact factor: 3.467

Review 2.  Focus on molecular events in the anterior chamber leading to glaucoma.

Authors:  Sergio Claudio Saccà; Alberto Izzotti
Journal:  Cell Mol Life Sci       Date:  2013-10-19       Impact factor: 9.261

Review 3.  Intraocular pressure homeostasis: maintaining balance in a high-pressure environment.

Authors:  Ted S Acott; Mary J Kelley; Kate E Keller; Janice A Vranka; Diala W Abu-Hassan; Xinbo Li; Mini Aga; John M Bradley
Journal:  J Ocul Pharmacol Ther       Date:  2014-01-08       Impact factor: 2.671

4.  Rho GTPase and cAMP/protein kinase A signaling mediates myocilin-induced alterations in cultured human trabecular meshwork cells.

Authors:  Xiang Shen; Takahisa Koga; Bum-Chan Park; Nirmala SundarRaj; Beatrice Y J T Yue
Journal:  J Biol Chem       Date:  2007-11-05       Impact factor: 5.157

5.  The role of integrin glycosylation in galectin-8-mediated trabecular meshwork cell adhesion and spreading.

Authors:  Shiri Diskin; Zhiyi Cao; Hakon Leffler; Noorjahan Panjwani
Journal:  Glycobiology       Date:  2008-10-11       Impact factor: 4.313

6.  TRPV4-Rho signaling drives cytoskeletal and focal adhesion remodeling in trabecular meshwork cells.

Authors:  Monika Lakk; David Križaj
Journal:  Am J Physiol Cell Physiol       Date:  2021-03-31       Impact factor: 5.282

7.  Testosterone Pathway Genetic Polymorphisms in Relation to Primary Open-Angle Glaucoma: An Analysis in Two Large Datasets.

Authors:  Jessica N Cooke Bailey; Puya Gharahkhani; Jae H Kang; Mariusz Butkiewicz; David A Sullivan; Robert N Weinreb; Hugues Aschard; R Rand Allingham; Allison Ashley-Koch; Richard K Lee; Sayoko E Moroi; Murray H Brilliant; Gadi Wollstein; Joel S Schuman; John H Fingert; Donald L Budenz; Tony Realini; Terry Gaasterland; William K Scott; Kuldev Singh; Arthur J Sit; Robert P Igo; Yeunjoo E Song; Lisa Hark; Robert Ritch; Douglas J Rhee; Douglas Vollrath; Donald J Zack; Felipe Medeiros; Thasarat S Vajaranant; Daniel I Chasman; William G Christen; Margaret A Pericak-Vance; Yutao Liu; Peter Kraft; Julia E Richards; Bernard A Rosner; Michael A Hauser; Jamie E Craig; Kathryn P Burdon; Alex W Hewitt; David A Mackey; Jonathan L Haines; Stuart MacGregor; Janey L Wiggs; Louis R Pasquale
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.